Regulon

Regulon: R-3266

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
71.3878410Pr-8Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
4854 ENSG00000074181 NOTCH3 Q9UM47
11078 ENSG00000100106 TRIOBP Q9H2D6
5159 ENSG00000113721 PDGFRB P09619
7837 ENSG00000130508 PXDN Q92626
8291 ENSG00000135636 DYSF O75923
2615 ENSG00000137507 LRRC32 Q14392
4782 ENSG00000141905 NFIC P08651

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
PAZOPANIBLCKSmall moleculeINHIBITORFibroblast growth factor receptor 1 inhibitor41
MIDOSTAURINKITSmall moleculeINHIBITORVascular endothelial growth factor receptor 2 inhibitor40
CRENOLANIBPDGFRBSmall moleculeINHIBITORTyrosine-protein kinase receptor FLT3 inhibitor32
TIVOZANIBKITSmall moleculeINHIBITORVascular endothelial growth factor receptor inhibitor42
SUNITINIBPDGFRBSmall moleculeINHIBITORPlatelet-derived growth factor receptor inhibitor42
SORAFENIB TOSYLATEPDGFRBSmall moleculeINHIBITORStem cell growth factor receptor inhibitor42
DASATINIBABL1Small moleculeINHIBITORPlatelet-derived growth factor receptor beta inhibitor42
TELATINIBKITSmall moleculeINHIBITORVascular endothelial growth factor receptor 2 inhibitor20
SORAFENIBFLT3Small moleculeINHIBITORStem cell growth factor receptor inhibitor42
PAZOPANIB HYDROCHLORIDELCKSmall moleculeINHIBITORFibroblast growth factor receptor 1 inhibitor40
VATALANIBKITSmall moleculeINHIBITORPlatelet-derived growth factor receptor inhibitor31
TANDUTINIBFLT3Small moleculeINHIBITORPlatelet-derived growth factor receptor beta inhibitor22
NINTEDANIB ESYLATEFGFR3Small moleculeINHIBITORFibroblast growth factor receptor inhibitor40
FORETINIBTEKSmall moleculeINHIBITORTyrosine-protein kinase TIE-2 inhibitor20
IMATINIB MESYLATEABL1Small moleculeINHIBITORBcr/Abl fusion protein43
SUNITINIB MALATEPDGFRBSmall moleculeINHIBITORPlatelet-derived growth factor receptor inhibitor42
XL-999PDGFRBSmall moleculeINHIBITORFibroblast growth factor receptor inhibitor20
X-82PDGFRBSmall moleculeINHIBITORVascular endothelial growth factor receptor inhibitor20
DOVITINIBPDGFRBSmall moleculeINHIBITORVascular endothelial growth factor receptor inhibitor31
BECAPLERMINPDGFRBProteinAGONISTPlatelet-derived growth factor receptor agonist40
SU-014813PDGFRBSmall moleculeINHIBITORVascular endothelial growth factor receptor inhibitor20
ILORASERTIBPDGFRBSmall moleculeINHIBITORSerine/threonine-protein kinase Aurora inhibitor20
ANLOTINIBKITSmall moleculeINHIBITORVascular endothelial growth factor receptor 3 inhibitor32
IMATINIBABL1Small moleculeINHIBITORBcr/Abl fusion protein43
JI-101PDGFRBSmall moleculeINHIBITOREphrin type-B receptor 4 inhibitor20
TAREXTUMABNOTCH3AntibodyINHIBITORNeurogenic locus notch homolog protein 3 inhibitor10
XL-820KITSmall moleculeINHIBITORPlatelet-derived growth factor receptor inhibitor20
NINTEDANIBFGFR3Small moleculeINHIBITORFibroblast growth factor receptor inhibitor42
MASITINIBKITSmall moleculeINHIBITORStem cell growth factor receptor inhibitor30
TG100-801EPHB4Small moleculeINHIBITORSRC inhibitor20
MOTESANIBKDRSmall moleculeINHIBITORTyrosine-protein kinase receptor RET inhibitor30
ORANTINIBPDGFRBSmall moleculeINHIBITORFibroblast growth factor receptor inhibitor30
RG-1530KDRSmall moleculeINHIBITORVascular endothelial growth factor receptor inhibitor10
QUIZARTINIBPDGFRBSmall moleculeINHIBITORTyrosine-protein kinase receptor FLT3 inhibitor30
RINUCUMABPDGFRBAntibodyINHIBITORPlatelet-derived growth factor receptor beta inhibitor20
TAK-593PDGFRBSmall moleculeINHIBITORPlatelet-derived growth factor receptor inhibitor10
LINIFANIBCSF1RSmall moleculeINHIBITORPlatelet-derived growth factor receptor inhibitor30
CM-082FLT3Small moleculeINHIBITORVascular endothelial growth factor receptor 2 inhibitor30
CEDIRANIBKITSmall moleculeINHIBITORPlatelet-derived growth factor receptor inhibitor33
REGORAFENIBKDRSmall moleculeINHIBITORTyrosine-protein kinase TIE-2 inhibitor42
FAMITINIBKDRSmall moleculeINHIBITORPlatelet-derived growth factor receptor inhibitor30
TIVOZANIB HYDROCHLORIDEKITSmall moleculeINHIBITORVascular endothelial growth factor receptor inhibitor40
ENMD-981693PDGFRBSmall moleculeINHIBITORPlatelet-derived growth factor receptor inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-3266

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs